| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(200112)44:12<2746::AID-ART461>3.0.CO;2-Z |
| P698 | PubMed publication ID | 11762934 |
| P2093 | author name string | G Singh | |
| J B Wong | |||
| D R Ramey | |||
| P433 | issue | 12 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 2746-2749 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Long-term morbidity, mortality, and economics of rheumatoid arthritis | |
| P478 | volume | 44 |
| Q36055449 | An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists |
| Q86056592 | Artesunate Ameliorates Functional Limitations in Freund's Complete Adjuvant-Induced Monoarthritis in Rat by Maintaining Oxidative Homeostasis and Inhibiting COX-2 Expression |
| Q34344584 | Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis |
| Q35554270 | Burden and cost of illness in patients with juvenile idiopathic arthritis |
| Q33943374 | Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment |
| Q58797371 | Copy Number of Human Ribosomal Genes With Aging: Unchanged Mean, but Narrowed Range and Decreased Variance in Elderly Group |
| Q35823650 | Effective use of TNF antagonists |
| Q78431457 | Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis |
| Q42283690 | Identification of key genes associated with rheumatoid arthritis with bioinformatics approach |
| Q45400598 | Identification of transcription regulatory relationships in rheumatoid arthritis and osteoarthritis |
| Q37172804 | Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group |
| Q35632732 | Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis |
| Q35152141 | Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis |
| Q35851012 | Modeling rheumatoid arthritis using different techniques - a review of model construction and results. |
| Q24684208 | Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis |
| Q85062884 | Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis |
| Q24202719 | Ofatumumab for rheumatoid arthritis |
| Q31105692 | Recommendations from the Community Oriented Program for Control of Rheumatic Disease for data collection for the measurement and monitoring of health in developing countries |
| Q28710161 | Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study |
| Q35780357 | Review of health economics modelling in rheumatoid arthritis |
| Q37083070 | Screening of gene signatures for rheumatoid arthritis and osteoarthritis based on bioinformatics analysis. |
| Q33619855 | Supplementation of diet with krill oil protects against experimental rheumatoid arthritis. |
| Q35553191 | TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden |
| Q81478994 | The case for stratified cost-effectiveness analysis by baseline health-related QOL: theory and sensitivity analysis |
| Q53854537 | The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK. |
| Q37583037 | Utilization patterns of disease-modifying antirheumatic drugs in elderly rheumatoid arthritis patients |
| Q40179653 | miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis |
Search more.